Livmedi - Company finances
|
EUR
|
2020
From: 2020-12-29
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | 0 | 0 | - | 6,490 | 39,196 | 15,434 |
| Profit before tax | 0 | -18,580 | -42,364 | -21,430 | -35,314 | 16,138 |
| Net profit | 0 | -18,580 | -42,364 | -21,430 | -35,314 | 16,138 |
| Equity | 2,500 | -16,080 | -58,444 | -79,874 | -115,188 | -492 |
| Liabilities | 0 | 70,946 | 108,037 | 190,346 | 199,372 | 37,352 |
| Non-current assets | 0 | 2,490 | 2,490 | 2,490 | 0 | 0 |
| Current assets | 2,500 | 52,376 | 47,103 | 107,842 | 84,184 | 36,860 |
| Total assets | 2,500 | 54,866 | 49,593 | 110,332 | 84,184 | 36,860 |
|
Financial indicators
|
||||||
| Revenue change y/y | - | - | - | - | +503.9% | -60.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | -33.9% | -85.4% | -19.4% | -41.9% | 43.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - | -330.2% | -90.1% | 104.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | -330.2% | -90.1% | 104.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | 6,490 | 39,196 | 15,434 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Livmedi - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-06-18 | 2024-06-25 | 142.96 |
Livmedi - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-06-01 | 2026-06-05 | 4.42 |
| 2026-05-17 | 2026-05-31 | 3.6 |
| 2026-05-14 | 2026-05-16 | 1527.91 |
| 2026-05-06 | 2026-05-13 | 1662.77 |
| 2026-05-01 | 2026-05-05 | 1660.52 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Livmedi, UAB (code 305673270) is a Private Limited Liability Company engaged in the manufacture of other food products n.e.c. In 2025, the company generated revenue of €15.4K and net profit of €16.1K, after posting losses in the previous two years. The 2024 turnover was €39.2K with a net loss of €35.3K, while 2023 revenue stood at €6.5K and the net loss was €21.4K. This shows a volatile revenue pattern, with 2025 revenue down 60.6% year on year, but still 137.8% above 2023. Profitability improved materially in 2025, and the company reported a positive margin as profit exceeded revenue. At the same time, the balance sheet remained constrained: total assets were €36.9K, equity was slightly negative at -€492, and liabilities amounted to €37.4K. The asset turnover ratio was 0.42x. Revenue per employee was €15.4K and profit per employee was €16.1K, indicating modest operating scale in 2025.